PMID- 15307911 OWN - NLM STAT- MEDLINE DCOM- 20040915 LR - 20181113 IS - 0889-2229 (Print) IS - 1931-8405 (Electronic) IS - 0889-2229 (Linking) VI - 20 IP - 7 DP - 2004 Jul TI - Human leukocyte antigen (HLA) B*18 and protection against mother-to-child HIV type 1 transmission. PG - 692-7 AB - Human leukocyte antigen (HLA) molecules regulate the cellular immune system and may be determinants of infant susceptibility to human immunodeficiency virus type 1 (HIV-1) infection. Molecular HLA typing for class I alleles was performed on infants followed in a Kenyan perinatal cohort. Early HIV-1 infection status was defined as infection occurring at birth or month 1, while late infection via breast milk was defined as first detection of HIV-1 after 1 month of age. Likelihood ratio tests based on a proportional hazards model adjusting for maternal CD4 T cell count and HIV-1 viral load at 32 weeks of gestation were used to test associations between infant allelic variation and incident HIV-1 infection. Among 433 infants, 76 (18%) were HIV-1 infected during 12 months of follow-up. HLA B*18 was associated with a significantly lower risk of early HIV-1 transmission [relative risk (RR) = 0.26; 95% confidence interval (CI) 0.04-0.82], and none of the 24 breastfeeding infants expressing HLA B*18 who were uninfected at month 1 acquired HIV-1 late via breast milk. We observed a trend toward increased early HIV-1 acquisition for infants presenting HLA A*29 (RR = 2.0; 95% CI 1.0-3.8) and increased late HIV-1 acquisition via breast milk for both Cw*07 and Cw*08 (RR = 4.0; 95% CI 1.0-17.8 and RR = 7.2; 95% CI 1.2-37.3, respectively). HLA B*18 may protect breast-feeding infants against both early and late HIV-1 acquisition, a finding that could have implications for the design and monitoring of HIV-1 vaccines targeting cellular immune responses against HIV-1. FAU - Farquhar, Carey AU - Farquhar C AD - Department of Medicine, University of Washington, Seattle, Washington 98104, USA. cfarq@u.washington.edu FAU - Rowland-Jones, Sarah AU - Rowland-Jones S FAU - Mbori-Ngacha, Dorothy AU - Mbori-Ngacha D FAU - Redman, Mary AU - Redman M FAU - Lohman, Barbara AU - Lohman B FAU - Slyker, Jennifer AU - Slyker J FAU - Otieno, Phelgona AU - Otieno P FAU - Obimbo, Elizabeth AU - Obimbo E FAU - Rostron, Timothy AU - Rostron T FAU - Ochieng, James AU - Ochieng J FAU - Oyugi, Julius AU - Oyugi J FAU - Bosire, Rose AU - Bosire R FAU - John-Stewart, Grace AU - John-Stewart G LA - eng GR - K23 HD-41879/HD/NICHD NIH HHS/United States GR - D43-TW00007/TW/FIC NIH HHS/United States GR - D43 TW000007/TW/FIC NIH HHS/United States GR - R01 HD023412-19/HD/NICHD NIH HHS/United States GR - R01 HD023412/HD/NICHD NIH HHS/United States GR - P30 AI027757-14/AI/NIAID NIH HHS/United States GR - P30 AI027757/AI/NIAID NIH HHS/United States GR - K23 HD041879/HD/NICHD NIH HHS/United States GR - R01 HD-23412/HD/NICHD NIH HHS/United States GR - K01 AI087369/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - AIDS Res Hum Retroviruses JT - AIDS research and human retroviruses JID - 8709376 RN - 0 (HLA-A Antigens) RN - 0 (HLA-B Antigens) RN - 0 (HLA-B18 Antigen) RN - 0 (HLA-C Antigens) SB - IM MH - Acquired Immunodeficiency Syndrome/*immunology/prevention & control MH - CD4 Lymphocyte Count MH - Female MH - HLA-A Antigens/immunology MH - HLA-B Antigens/*immunology MH - HLA-B18 Antigen MH - HLA-C Antigens/immunology MH - Histocompatibility Testing MH - Humans MH - Infectious Disease Transmission, Vertical/*prevention & control MH - Pregnancy MH - Pregnancy Complications, Infectious/*virology MH - Viral Load PMC - PMC3380108 MID - NIHMS359248 EDAT- 2004/08/17 10:00 MHDA- 2004/09/16 05:00 PMCR- 2012/06/20 CRDT- 2004/08/17 10:00 PHST- 2004/08/17 10:00 [pubmed] PHST- 2004/09/16 05:00 [medline] PHST- 2004/08/17 10:00 [entrez] PHST- 2012/06/20 00:00 [pmc-release] AID - 10.1089/0889222041524616 [doi] PST - ppublish SO - AIDS Res Hum Retroviruses. 2004 Jul;20(7):692-7. doi: 10.1089/0889222041524616.